Table: Mochida Pharm -Q1 group results

Mochida Pharmaceutical

01/08/2025 06:00

Aug 1 (Reuters)- 
             Mochida Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             26.63               25.41           110.50    
                 (+4.8 pct)          (+2.7 pct)       (+5.1 pct)  
  Operating          2.57                2.19             7.00    
                 (+17.5 pct)         (-13.0 pct)      (-13.9 pct) 
  Recurring          2.78                2.37             7.50    
                 (+17.6 pct)         (-8.7 pct)       (-7.0 pct)  
  Net                1.89                1.55             5.40    
                 (+21.8 pct)         (-7.9 pct)       (-5.0 pct)  
  EPS             53.43 yen           43.85 yen       152.33 yen  
  Ann Div                             80.00 yen        80.00 yen  
  -Q2 div                             40.00 yen        40.00 yen  
  -Q4 div                             40.00 yen        40.00 yen  
  
  NOTE - Mochida Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T